MRNA – moderna, inc. (US:NASDAQ)
Stock Stats
News
U.S. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Market Research: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [Yahoo! Finance]
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? [Yahoo! Finance]
Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
Moderna, Inc. (NASDAQ: MRNA) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $41.00 price target on the stock.
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $45.00. They now have an "underweight" rating on the stock.
Form 4 Moderna, Inc. For: Dec 06 Filed by: Klinger Shannon Thyme
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
Form 4 Moderna, Inc. For: Dec 05 Filed by: Mock James M
Form 4 Moderna, Inc. For: Dec 05 Filed by: Klinger Shannon Thyme
Form 4 Moderna, Inc. For: Dec 02 Filed by: Klinger Shannon Thyme
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.